Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Finch Therapeutics Group, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −4 vs. Q2 2022
- Shares held
- 10.0M
- +178.4K (+1.8%) vs. Q2 2022
- Total value
- $16.8M
- −$11.2M (−40.1%) vs. Q2 2022
- New holders
- 4
- 9 more added
- Sold out
- 8
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FNCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 1 | $29.1K |
| Q1 2024 | 11 | $338.2K |
| Q4 2023 | 17 | $754.7K |
| Q3 2023 | 18 | $1.37M |
| Q2 2023 | 17 | $2.16M |
| Q1 2023 | 33 | $3.75M |
| Q4 2022 | 40 | $4.60M |
| Q3 2022 | 43 | $16.8M |
| Q2 2022 | 47 | $28.0M |
| Q1 2022 | 53 | $53.1M |
| Q4 2021 | 51 | $115.0M |
| Q3 2021 | 45 | $106.8M |
| Q2 2021 | 46 | $77.2M |
| Q1 2021 | 36 | $108.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Finch Therapeutics Group, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 223 | $0 | 0.00% | −3,357−93.8% | Reduced |
| FMR LLC | 270 | $0 | 0.00% | −600−69.0% | Reduced |
| Wells Fargo & Company | 152 | $0 | 0.00% | +101+198.0% | Added |
| Barclays PLC | 106 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 160 | $0 | 0.00% | +160 | New |
| Morgan Stanley | 823 | $1.00K | 0.00% | −26,782−97.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,535 | $2.00K | 0.00% | −144−8.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,039 | $2.00K | 0.00% | +110+11.8% | Added |
| Steward Partners Investment Advisory, LLC | 2,250 | $4.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,236 | $14.0K | 0.00% | +1,795+27.9% | Added |
| Dimensional Fund Advisors LP | 10,037 | $17.0K | 0.00% | +10,037 | New |
| Wealthsource Partners, LLC | 11,500 | $19.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 14,131 | $22.0K | 0.00% | −6,968−33.0% | Reduced |
| Virtu Financial LLC | 15,190 | $25.0K | 0.00% | +15,190 | New |
| Ancora Advisors, LLC | 16,000 | $27.0K | 0.00% | −15,746−49.6% | Reduced |
| Charles Schwab Investment Management Inc | 18,783 | $32.0K | 0.00% | −13,791−42.3% | Reduced |
| Boothbay Fund Management, LLC | 23,887 | $40.0K | 0.00% | −17,337−42.1% | Reduced |
| State Street Corp | 24,479 | $41.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 25,259 | $42.0K | 0.00% | +11,016+77.3% | Added |
| Goldman Sachs Group Inc | 25,716 | $43.0K | 0.00% | −8,795−25.5% | Reduced |
| SCS Capital Management LLC | 38,294 | $64.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 40,600 | $68.0K | 0.00% | +1,900+4.9% | Added |
| Laurion Capital Management LP | 58,000 | $97.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 64,267 | $107.0K | 0.00% | +11,293+21.3% | Added |
| BlackRock Inc. | 70,429 | $117.0K | 0.00% | +3,680+5.5% | Added |
| Proficio Capital Partners LLC | 110,559 | $185.0K | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 120,907 | $202.0K | 0.00% | +29,865+32.8% | Added |
| Ballentine Partners, LLC | 143,603 | $240.0K | 0.01% | 00.0% | Unchanged |
| Aperture Investors, LLC | 192,794 | $322.0K | 0.05% | −14,935−7.2% | Reduced |
| Geode Capital Management, LLC | 210,180 | $351.0K | 0.00% | +106,734+103.2% | Added |
| Oasis Management Co Ltd. | 225,000 | $376.0K | 0.06% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 237,553 | $397.0K | 0.20% | −92,970−28.1% | Reduced |
| Boston Private Wealth LLC | 253,054 | $423.0K | 0.01% | +253,054 | New |
| MSD Partners, L.P. | 388,691 | $649.0K | 0.07% | 00.0% | Unchanged |
| TRB Advisors LP | 570,000 | $952.0K | 0.94% | 00.0% | Unchanged |
| Lake Street Advisors Group, LLC | 739,136 | $1.23M | 0.09% | 00.0% | Unchanged |
| Bleichroeder LP | 810,416 | $1.35M | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,010,134 | $1.69M | 0.00% | 00.0% | Unchanged |
| Baupost Group LLCSuperinvestorBaupost Group | 1,123,108 | $1.88M | 0.03% | 00.0% | Unchanged |
| Avenir Management Company, LLC | 1,663,366 | $2.78M | 4.72% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 1,770,858 | $2.96M | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −36,600−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,778−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −3,175−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −337−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |